Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

C003 - Live Demonstration: The State of The Art of Aesthetic Dermatology

Friday, March 1; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Assess the aging face and neck and select the most appropriate aesthetic technique
  • Identify the various ambulatory cosmetic procedures and their appropriate uses.
  • Recognize and identify facial and neck anatomy as it relates to the use of elective procedures

Description

This live interactive session will feature experts from around the country demonstrating their techniques and treatment tips with cosmetic procedures. Attendees will observe in a live interactive manner precisely how the faculty assess the aging face and go about treating the various areas of the entire face from brow to neck and a few select non-facial areas. Each area will be treated by one of the faculty while another physician discusses the procedure and facilitates dialogue with the audience. There will be discussion and demonstration of the optimal techniques using many of the FDA approved fillers, neuromodulators, deoxycholic acid, chemical peels and microneedling.

Disclosures

  • Alam, Murad, MD: Pulse Biosciences – C(Fees);
  • Alster, Tina S., MD: A Method – C(OB); Cearna, Inc – A(OB); Collagen P.I.N. – A(NC); Galderma USA – I(Grants/Research Funding); Hair Sanity – SH(ST); Home Skinovations – C(ST); Merz Aesthetics – A(H); Revance Therapeutics, Inc. – I(Grants/Research Funding);
  • Brody, Harold J., MD: Allergan, Inc. – SP(H); Galderma Laboratories, LP – SP(H); Merz Aesthetics – SP(H);
  • Burgess, Cheryl M., MD: Aclaris Therapeutics Inc. – I(Grants/Research Funding), SP(H); Allergan, Inc. – I(Grants/Research Funding), SH(ST); Dermira – SP(H); Galderma USA – A(H); Kythera – I(Grants/Research Funding); Merz Aesthetics – A(H), I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sinclair Pharma – A(H);
  • Butterwick, Kimberly J., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(H); Colorescience – A(H); Evolus, Inc. – A(H); Galderma Laboratories, L.P. – A(H), I(Grants/Research Funding); Histogen Inc. – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – A(H); Revance Therapeutics, Inc. – A(H); Sinclair Pharma, LLC – Speaker/Faculty Education(H);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candela Corporation – A(H); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – A(NC); Valeant Pharmaceuticals North America LLC – C(H);
  • Hooper, Deirdre, MD: Allergan, Inc – A(H), C(H), SP(H); Almirall – C(H); Asana Biosciences, LLC – I(H); Bellus Medical – A(H); BioPharmX – I(H); Botanix Pharmaceuticals – I(H); Bristol-Myers Squibb – I(H); Clarisonic – C(H); Cutera, Inc. – SP(H); Dermavant Sciences – I(H); Dermira – I(H); Dr Reddy's Laboratory – I(H); DS Biopharma – I(H); Endo International plc – I(H); Evolus, Inc. – A(H); Ferndale Laboratories, Inc. – A(H); Foamix – I(H); Galderma USA – SP(H); Glenmark Generics Inc. – I(H); Incyte Corporation – I(H); Kinex Medical – I(H); La Roche-Posay Laboratorie Pharmaceutique – C(H); Menlo Therapeutics – I(H); Novartis – I(H); PCA SKIN – SP(H); Pfizer Inc. – SP(H); Pixacore – C(H); Qurient, Inc. – I(H); RBC Consultants – C(H); Revance Therapeutics, Inc. – C(H); Sinclair Pharma – A(H); Sol-Gel Technologies – I(H); UCB – I(H); Viviscal – C(H);
  • Keaney, Terrence, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc – A(H), I(Fees), SP(H); Eclipse Medical – SP(H); Evolus, Inc. – A(H); Merz Aesthetics – A(H); SkinCeauticals LLC – I(H); Syneron Candela – A(H), SP(H); Unilever – C(H);
  • Mariwalla, Kavita, MD: Aclaris Therapeutics Inc. – C(Fees); Galderma Argentina, S.A. – SP(Fees); Revance Therapeutics, Inc. – I(Grants/Research Funding); Skinfix, Inc. – C(Fees);
  • Matarasso, Seth L., MD: no financial relationships exist with commercial interests.
  • Monheit, Gary D., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Evolus, Inc. – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H), I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Suneva Medical, Inc. – C(NC), I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Narins, Rhoda S., MD: Allergan, Inc. – C(H); Galderma USA – I(Grants/Research Funding); Merz Aesthetics – C(H); Revance Therapeutics, Inc. – A(H); Suneva Medical, Inc. – I(Grants/Research Funding);
  • Ozog, David M., MD: Biofrontera AG – I(Grants/Research Funding), SH(NC); Galderma USA – I(Grants/Research Funding); miRagen Therapeutics, Inc. – I(Grants/Research Funding);
  • Palm, Melanie, MD: Allergan, Inc – A(H); AmperSand Biopharmaceutical, LLC – I(Fees); BTL Industries – Speaker/Faculty Education(H); Galderma Laboratories, L.P. – C(H); Kythera – Speaker/Faculty Education(H); Lumenis – SP(H); Lutronics, Inc. – C(OB); Merz Aesthetics – Speaker/Faculty Education(H); Valeant Pharmaceuticals International – C(H);
  • Skelsey, Maral Kibarian, MD: Dermira – A(Fees); DermTech International – I(NC);
  • Solish, Nowell J., MD: Allergan, Inc – A(H); Allergan, Inc. – SP(H); Galderma USA – SP(H); International hyperhidrosis society – B(H); Revance Therapeutics, Inc. – A(H);
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
Event Details
  • Date
    Friday, March 1
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 202A
  • CME Credits
    3.00
  • Type
    Ticketed
    Restricted
Directors/Co-Directors
  • Seth L. Matarasso, MD, FAAD
Speakers
  • Cheryl M. Burgess, MD, FAAD
  • David M. Ozog, MD, FAAD
  • Deirdre Hooper, MD, FAAD
  • Gary D. Monheit, MD, FAAD
  • Harold J. Brody, MD, FAAD
  • Kavita Mariwalla, MD, FAAD
  • Kimberly J. Butterwick, MD, FAAD
  • Maral Kibarian Skelsey, MD, FAAD
  • Melanie Palm, MD, FAAD
  • Murad Alam, MD, FAAD
  • Nowell J. Solish, MD, FAAD
  • Rhoda S. Narins, MD, FAAD
  • Sue Ellen Cox, MD, FAAD
  • Susan H. Weinkle, MD, FAAD
  • Terrence Keaney, MD, FAAD
  • Tina S. Alster, MD, FAAD